Literature DB >> 25805904

Essential Oils, Silver Nanoparticles and Propolis as Alternative Agents Against Fluconazole Resistant Candida albicans, Candida glabrata and Candida krusei Clinical Isolates.

Piotr Szweda1, Katarzyna Gucwa1, Ewelina Kurzyk2, Ewa Romanowska3, Katarzyna Dzierżanowska-Fangrat3, Anna Zielińska Jurek4, Piotr Marek Kuś5, Sławomir Milewski1.   

Abstract

Development of effective and safe therapeutic treatment of fungal infections remains one of the major challenge for modern medicine. The aim of presented investigation was to analyze the in vitro antifungal activity of selected essential oils, ethanolic extracts of propolis and silver nanoparticles dropped on TiO2 against azole-resistant C. albicans (n = 20), C. glabrata (n = 14) and C. krusei (n = 10) clinical isolates. Among tested essential oils, the highest activity has definitely been found in the case of the oil isolated from the bark of Cinnamomum cassia, with MIC and MFC values for all tested strains in the range of 0.0006-0.0097 % (v/v) and 0.0012-0.019 % (v/v), respectively. High activity was also observed for the Lemon, Basil, Thyme, Geranium and Clove (from buds) essential oils. Significant differences in fungicidal activity have been observed in the case of four tested propolis samples. Only one of them revealed high activity, with MFC values in the range from 0.156 to 1.25 % (v/v). Satisfactory fungicidal activity, against C. albicans and C. glabrata isolates, was also observed in the case of silver nanoparticles, however C. krusei isolates were mostly resistant. We also revealed that constituents of most of essential oils and propolis as well as silver nanoparticles are not substrates for drug transporters, which belong to the most important factors affecting resistance of Candida spp. clinical isolates to many of conventional antimycotics. To conclude, the results of our investigation revealed that essential oils, propolis and silver nanoparticles represent high potential for controlling and prevention candidiasis.

Entities:  

Keywords:  Candida albicans; Candida glabrata; Candida krusei; Essential oils; Propolis; Silver nanoparticles

Year:  2014        PMID: 25805904      PMCID: PMC4363251          DOI: 10.1007/s12088-014-0508-2

Source DB:  PubMed          Journal:  Indian J Microbiol        ISSN: 0046-8991            Impact factor:   2.461


  28 in total

1.  Antimicrobial activity of propolis special extract GH 2002 against multidrug-resistant clinical isolates.

Authors:  A Astani; S Zimmermann; E Hassan; J Reichling; K H Sensch; P Schnitzler
Journal:  Pharmazie       Date:  2013-08       Impact factor: 1.267

2.  Molecular aspects of fluconazole resistance development in Candida albicans.

Authors:  R Franz; M Ruhnke; J Morschhäuser
Journal:  Mycoses       Date:  1999       Impact factor: 4.377

3.  Antimicrobial activities of cinnamon oil and cinnamaldehyde from the Chinese medicinal herb Cinnamomum cassia Blume.

Authors:  Linda S M Ooi; Yaolan Li; Sheung-Lau Kam; Hua Wang; Elaine Y L Wong; Vincent E C Ooi
Journal:  Am J Chin Med       Date:  2006       Impact factor: 4.667

Review 4.  Epidemiology of invasive mycoses in North America.

Authors:  Michael A Pfaller; Daniel J Diekema
Journal:  Crit Rev Microbiol       Date:  2010       Impact factor: 7.624

5.  Effect of seasonality on chemical composition and antibacterial and anticandida activities of Argentine propolis. Design of a topical formulation.

Authors:  María Inés Isla; Yanina Dantur; Ana Salas; Carolina Danert; Catiana Zampini; Myriam Arias; Roxana Ordóñez; Luis Maldonado; Enrique Bedascarrasbure; María Inés Nieva Moreno
Journal:  Nat Prod Commun       Date:  2012-10       Impact factor: 0.986

6.  Antifungal Activity of Brazilian Propolis Microparticles against Yeasts Isolated from Vulvovaginal Candidiasis.

Authors:  Kelen Fátima Dalben Dota; Marcia Edilaine Lopes Consolaro; Terezinha Inez Estivalet Svidzinski; Marcos Luciano Bruschi
Journal:  Evid Based Complement Alternat Med       Date:  2011-03-09       Impact factor: 2.629

7.  Quantitative and qualitative analyses of the cell death process in Candida albicans treated by antifungal agents.

Authors:  Kyung Sook Kim; Young-Sun Kim; Ihn Han; Mi-Hyun Kim; Min Hyung Jung; Hun-Kuk Park
Journal:  PLoS One       Date:  2011-12-09       Impact factor: 3.240

8.  Brazilian green propolis compared to miconazole gel in the treatment of Candida-associated denture stomatitis.

Authors:  Hermínia Marques Capistrano; Eliene Magda de Assis; Rosana Maria Leal; Maria Eugênia Alvarez-Leite; Sylvie Brener; Esther Margarida Alves Ferreira Bastos
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-02       Impact factor: 2.629

Review 9.  Emerging and emerged pathogenic Candida species: beyond the Candida albicans paradigm.

Authors:  Nicolas Papon; Vincent Courdavault; Marc Clastre; Richard J Bennett
Journal:  PLoS Pathog       Date:  2013-09-26       Impact factor: 6.823

10.  The influence of chemical composition of commercial lemon essential oils on the growth of Candida strains.

Authors:  M Białoń; T Krzyśko-Łupicka; M Koszałkowska; P P Wieczorek
Journal:  Mycopathologia       Date:  2014-01-12       Impact factor: 2.574

View more
  15 in total

1.  Promising Anti-Biofilm Agents and Phagocytes Enhancers for the Treatment of Candida albicans Biofilm-Associated Infections.

Authors:  Yasmine H Tartor; Gamal A Elmowalid; Mohamed N Hassan; Asmaa Shaker; Dalia F Ashour; Taisir Saber
Journal:  Front Cell Infect Microbiol       Date:  2022-07-01       Impact factor: 6.073

2.  In vitro antifungal activity of silver nanoparticles against fluconazole-resistant Candida species.

Authors:  Jhon J Artunduaga Bonilla; Daissy J Paredes Guerrero; Clara I Sánchez Suárez; Claudia C Ortiz López; Rodrigo G Torres Sáez
Journal:  World J Microbiol Biotechnol       Date:  2015-09-03       Impact factor: 3.312

Review 3.  Propolis: A Complex Natural Product with a Plethora of Biological Activities That Can Be Explored for Drug Development.

Authors:  Ricardo Silva-Carvalho; Fátima Baltazar; Cristina Almeida-Aguiar
Journal:  Evid Based Complement Alternat Med       Date:  2015-05-27       Impact factor: 2.629

4.  Biosynthesis of silver nanoparticles using Caesalpinia ferrea (Tul.) Martius extract: physicochemical characterization, antifungal activity and cytotoxicity.

Authors:  Mônica R P S Soares; Rafael O Corrêa; Pedro Henrique F Stroppa; Flávia C Marques; Gustavo F S Andrade; Charlane C Corrêa; Marcos Antônio F Brandão; Nádia R B Raposo
Journal:  PeerJ       Date:  2018-03-19       Impact factor: 2.984

Review 5.  Lactoferrin, chitosan and Melaleuca alternifolia-natural products that show promise in candidiasis treatment.

Authors:  Lorena de Oliveira Felipe; Willer Ferreira da Silva Júnior; Katialaine Corrêa de Araújo; Daniela Leite Fabrino
Journal:  Braz J Microbiol       Date:  2017-11-11       Impact factor: 2.476

6.  Investigation of the Antifungal Activity and Mode of Action of Thymus vulgaris, Citrus limonum, Pelargonium graveolens, Cinnamomum cassia, Ocimum basilicum, and Eugenia caryophyllus Essential Oils.

Authors:  Katarzyna Gucwa; Sławomir Milewski; Tomasz Dymerski; Piotr Szweda
Journal:  Molecules       Date:  2018-05-08       Impact factor: 4.411

7.  Antifungal Activity and Synergism with Azoles of Polish Propolis.

Authors:  Katarzyna Gucwa; Barbara Kusznierewicz; Sławomir Milewski; Patrick Van Dijck; Piotr Szweda
Journal:  Pathogens       Date:  2018-06-19

Review 8.  Effects of Propolis on Infectious Diseases of Medical Relevance.

Authors:  Nelly Rivera-Yañez; C Rebeca Rivera-Yañez; Glustein Pozo-Molina; Claudia F Méndez-Catalá; Julia Reyes-Reali; María I Mendoza-Ramos; Adolfo R Méndez-Cruz; Oscar Nieto-Yañez
Journal:  Biology (Basel)       Date:  2021-05-12

9.  Antifungal Activity of Commercial Essential Oils and Biocides against Candida Albicans.

Authors:  Elisa Serra; Lilia Araida Hidalgo-Bastida; Joanna Verran; David Williams; Sladjana Malic
Journal:  Pathogens       Date:  2018-01-25

10.  The Anti-Staphylococcal Potential of Ethanolic Polish Propolis Extracts.

Authors:  Katarzyna Grecka; Piotr M Kuś; Piotr Okińczyc; Randy W Worobo; Justyna Walkusz; Piotr Szweda
Journal:  Molecules       Date:  2019-05-03       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.